The intracranial pressure monitoring devices market in Asia Pacific is expected to grow from US$ 281.53 million in 2023 to US$ 421.54 million by 2028. It is estimated to register a CAGR of 8.4% from 2023 to 2028.
Based on offering, the Asia Pacific intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products & systems segment held the largest share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on type, the Asia Pacific intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on application, the Asia Pacific intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on end user, the Asia Pacific intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on country, the Asia Pacific intracranial pressure monitoring devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific intracranial pressure monitoring devices market in 2023.
RAUMEDIC AG, Integra LifeSciences Holdings Corp, Medtronic Plc, and NovaSignal Corp are among the leading companies operating in the intracranial pressure monitoring devices market in Asia Pacific.
Increasing Prevalence of Neurological Diseases Fuels Asia Pacific Intracranial Pressure Monitoring Devices Market
Intracranial pressure (ICP) monitoring is crucial in diagnosing and treating neurological diseases such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, and meningitis/encephalitis. Bleeding in the brain, tumor, stroke, aneurysm, high blood pressure, or brain infection can lead to fluctuations in intracranial pressure. High ICP can cause headaches, blurred vision, vomiting, and other serious complications such as seizures, neurological damage, and death. According to the Asia Pacific Stroke Fact Sheet 2022, over 7.6 million new ischemic stroke cases are reported yearly, and over 62% of all incident strokes are ischemic strokes. Around 11% of all ischemic stroke cases occur in patients aged 15-49 years, and more than 58% occur in people under 70. Also, 55% of all ischemic stroke cases occur in women and 45% in men. Thus, the increasing prevalence of neurological diseases drives the growth of the Asia Pacific intracranial pressure (ICP) monitoring devices market.Asia Pacific Intracranial Pressure Monitoring Devices Market Overview
The Asia Pacific intracranial pressure (ICP) monitoring devices market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is growing at a significant rate and is expected to witness a notable growth during the forecast period owing to factors such as rising geriatric population, growing demand for minimally invasive procedures, rising awareness campaigns, and increasing incidence of neurological disorders. Moreover, the increase in number of research studies and surge in healthcare expenditure are expected to fuel the regional market growth during the forecast period.Asia Pacific Intracranial Pressure Monitoring Devices Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Intracranial Pressure Monitoring Devices Market Segmentation
The Asia Pacific intracranial pressure monitoring devices market is segmented into offering, type, application, end user, and country.Based on offering, the Asia Pacific intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products & systems segment held the largest share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on type, the Asia Pacific intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on application, the Asia Pacific intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on end user, the Asia Pacific intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on country, the Asia Pacific intracranial pressure monitoring devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific intracranial pressure monitoring devices market in 2023.
RAUMEDIC AG, Integra LifeSciences Holdings Corp, Medtronic Plc, and NovaSignal Corp are among the leading companies operating in the intracranial pressure monitoring devices market in Asia Pacific.
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Market Landscape
5. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Key Market Dynamics
6. Intracranial Pressure (ICP) Monitoring Devices Market - Asia Pacific Analysis
7. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By Offerings
8. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By Type
9. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By Application
10. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - By End User
11. Asia Pacific Intracranial Pressure (ICP) Monitoring Devices Market - Revenue and Forecast to 2028 - Country Analysis
12. Industry Landscape
13. Company Profile
14. Appendix
List of Tables
List of Figure
Companies Mentioned
- RAUMEDIC AG
- Integra LifeSciences Holdings Corp
- Medtronic Plc
- NovaSignal Corp
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | June 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 281.53 million |
| Forecasted Market Value ( USD | $ 421.54 million |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 4 |
